Co
ContraFect (Phibro)
Yonkers NYFounded 200830 employees
Private CapbiotechAcquiredInfectious Disease
Platform: Exebacase Phage
Market Cap
N/A
All Drugs
3
Clinical Trials
8
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tirainavolisib | CON-4041 | Phase 3 | 4 | FLT3 | Parkinson's | ||
| CON-544 | CON-544 | NDA/BLA | 2 | TIM-3 | SLEThymoma | ||
| CON-4833 | CON-4833 | Phase 2/3 | 2 | CD20 | SMACF |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (10)